Back to Agenda
Session 1 - FDA Update: Recent Enforcement Actions
Session Chair(s)
Wayne Pines
President, Health Care
United States
This session provides an overview of current issues, laws and guidances relevant to the promotion of prescription drugs, biologics and medical devices. Learn the latest on policy development, enforcement and FDA’s future initiatives.
Speaker(s)
CDER Update
Thomas W. Abrams, MBA, RPh
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
CDER Update
Barbara Chong, PharmD
FDA, United States
Special Assistant for Labeling, Office of Medical Policy, CDER
CBER Update
Lisa Stockbridge, PhD
FDA, United States
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER
Have an account?